Cantor Fitzgerald restated their overweight rating on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a report issued on Tuesday morning, Benzinga reports. The firm currently has a $85.00 price objective on the stock. DNLI has been the subject of several other reports. TheStreet raised Denali Therapeutics from a d rating to a c- […]
Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) Director Steve E. Krognes sold 1,419 shares of the company’s stock in a transaction on Monday, August 21st. The stock was sold at an average price of $22.60, for a total transaction of $32,069.40. Following the transaction, the director now owns 145,799 shares in the company, valued […]
Steve E Krognes Sells 1,419 Shares of Denali Therapeutics Inc (NASDAQ:DNLI) Stock wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Denali Therapeutics (NASDAQ:DNLI – Get Rating) had its price target decreased by Stifel Nicolaus to $30.00 in a research note released on Tuesday, The Fly reports. Several other equities analysts also recently issued reports on DNLI. SVB Securities initiated coverage on shares of Denali Therapeutics in a report on Monday, January 30th. They set an […]
Pier 88 Investment Partners LLC boosted its position in Denali Therapeutics Inc. (NASDAQ:DNLI – Get Rating) by 191.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 35,240 shares of the company’s stock after purchasing an additional 23,150 shares during the quarter. Pier 88 […]